China-developed nasal spray vaccine for COVID-19 approved for clinical trials
Xinhua |
Updated: 2020-09-09 22:17
Share
Share - WeChat
HONG KONG — The University of Hong Kong (HKU) Wednesday announced that the clinical trials of a nasal spray vaccine for COVID-19 jointly developed by the university's Department of Microbiology and mainland institutions have been approved.
The State Key Laboratory of Emerging Infectious Diseases has been working on the vaccine with Xiamen University and Beijing Wantai Biological Pharmacy.
It is the first nasal spray COVID-19 vaccine approved by the China's National Medical Products Administration for clinical trial in humans.
The HKU said in a statement that its vaccine strategy has been selected as one of the five vaccine technologies by the Ministry of Science and Technology for further evaluation.
- Gansu sets up team to probe abnormal blood lead levels in children
- China publishes Han-Tibetan version of major dictionary
- People advised to guard against dengue fever, diarrhea and other diseases
- Exploring China's Xixia Imperial Tombs with Yuanxi
- SCO foreign ministers council meeting to be held in Tianjin
- Foreign officials praise Chinese gardening culture for promoting harmony
